Boardroom Alpha
Boardroom Alpha
AFCG · Current Report (Form 8-K) · Filed January 16, 2026

Advanced Flower Capital Inc — Current Report (Form 8-K)

Form
8-K
Filed
January 16, 2026
Period
Jan 13, 2026
Ticker
AFCG
Accession
0001628280-26-002263
Boardroom Alpha · Filing insights

Advanced Flower Capital signs Sixth Amendment to its Loan and Security Agreement tied to its REIT-to-BDC conversion.

About Advanced Flower Capital Inc
Market cap
$88M
1Y TSR
−27.8%
3Y TSR
−18.7%
Board grade
C-
Sector
Real Estate
CEO
Daniel Neville
Last annual meeting: May 28, 2026 · View full Advanced Flower Capital Inc profile →
afcg-20260113

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 13, 2026
AFC_Lockup_1_primary.jpg
ADVANCED FLOWER CAPITAL INC.
(Exact name of Registrant as Specified in Its Charter)
Maryland001-3999585-1807125
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
477 S. Rosemary Ave., Suite 301
West Palm Beach, FL 33401
(Address of principal executive offices, including zip code)
561-510-2390
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareAFCGThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
1


Item 1.01    Entry into a Material Definitive Agreement
Amendment to Loan and Security Agreement
On January 13, 2026, Advanced Flower Capital Inc., a Maryland corporation (the “Company”), entered into Amendment Number Six to the Loan and Security Agreement (the “Sixth Amendment”), dated as of April 29, 2022 (as amended, supplemented or otherwise modified from time to time, including by the Sixth Amendment), by and among the Company, as borrower, the lenders party thereto and the lead arranger, bookrunner and administrative agent party thereto. The Sixth Amendment, among other things, includes provisions relevant in light of the Company’s conversion from a real estate investment trust to a business development company.
The foregoing description of the Sixth Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of Sixth Amendment, which is filed with this report as Exhibit 10.9F and incorporated herein by reference.
Item 2.03    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of Registrant
The information provided in Item 1.01 of this Current Report relating to the Sixth Amendment is incorporated by reference into this Item 2.03.
Item 9.01    Financial Statements and Exhibits
(d)Exhibits. The following exhibits are being filed with this Current Report.
Exhibit No.Description
Amendment Number Six, dated as of January 13, 2026, to the Loan and Security Agreement, dated as of April 29, 2022 (as amended, supplemented or otherwise modified from time to time, including by the Sixth Amendment), by and among the Company, as borrower, the lenders party thereto, and the lead arranger, bookrunner and administrative agent party thereto.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ADVANCED FLOWER CAPITAL INC.
By:/s/ Brandon Hetzel
Brandon Hetzel
Chief Financial Officer and Treasurer
Date: January 15, 2026
3
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Advanced Flower Capital Inc (AFCG)

Reference

Frequently asked questions

When did Advanced Flower Capital Inc file this 8-K?
Advanced Flower Capital Inc (AFCG) filed this Current Report (Form 8-K) with the SEC on January 16, 2026. The accession number assigned by EDGAR is 0001628280-26-002263.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Advanced Flower Capital signs Sixth Amendment to its Loan and Security Agreement tied to its REIT-to-BDC conversion. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Advanced Flower Capital Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Advanced Flower Capital Inc has filed under CIK 1822523, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer